tiprankstipranks
Anebulo Pharmaceuticals (ANEB)
OTHER OTC:ANEB
US Market
ANEB
Anebulo Pharmaceuticals
RESEARCH TOOLSreports
Want to see ANEB full AI Analyst Report?

Anebulo Pharmaceuticals (ANEB) Financial Statements

36 Followers

Anebulo Pharmaceuticals Financial Overview

Anebulo Pharmaceuticals's market cap is currently $20.39M. The company's EPS TTM is $-0.1942; its P/E ratio is -5.19; Anebulo Pharmaceuticals is scheduled to report earnings on May 7, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 25Jun 24Jun 23Jun 22Jun 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -9.22M$ -8.31M$ -11.78M$ -6.83M$ -3.61M
EBITDA$ -8.10M$ -7.79M$ -11.73M$ -6.83M$ -30.24M
Net Income$ -8.48M$ -8.20M$ -11.73M$ -6.83M$ -30.25M
Balance Sheet
Cash & Short-Term Investments$ 11.63M$ 3.09M$ 11.25M$ 14.55M$ 19.99M
Total Assets$ 12.15M$ 4.07M$ 11.67M$ 15.58M$ 21.65M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -11.63M$ -3.09M$ -11.25M$ -14.55M$ -19.99M
Total Liabilities$ 487.69K$ 260.58K$ 1.07M$ 512.53K$ 241.63K
Stockholders' Equity$ 11.66M$ 3.81M$ 10.60M$ 15.07M$ 21.41M
Cash Flow
Free Cash Flow$ -6.35M$ -8.09M$ -9.68M$ -5.44M$ -4.87M
Operating Cash Flow$ -6.35M$ -8.09M$ -9.68M$ -5.44M$ -4.87M
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 14.88M$ -62.35K$ 6.38M$ 0.00$ 21.83M
Currency in USD

Anebulo Pharmaceuticals Earnings and Revenue History

Income Statement >

Anebulo Pharmaceuticals Debt to Assets

Balance Sheet >

Anebulo Pharmaceuticals Cash Flow

Cash Flow >

Anebulo Pharmaceuticals Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
Earnings >